PEAR

Pear Therapeutics, Inc. Class A Common Stock
PEAR

Delisted

PEAR was delisted on the 18th of April, 2023.

Back to rankings

72 hedge funds and large institutions have $203M invested in Pear Therapeutics, Inc. Class A Common Stock in 2021 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

Holders
72
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$13.9M
2
+$12.9M
3
+$11.9M
4
Nomura Holdings
Nomura Holdings
Japan
+$11.6M
5
Citadel Advisors
Citadel Advisors
Florida
+$9.89M

Top Sellers

1
-$13.5K
2
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$17M
2
$13.9M
3
$12.9M
4
$11.9M
5
$11.6M
6
$7.35M
7
$7.16M
8
$6.9M
9
$6.85M
10
$6.51M
11
$5.44M
12
$5.44M
13
$5.19M
14
$4.95M
15
$4.94M
16
$4.9M
17
$3.46M
18
$3.45M
19
$3.41M
20
$3.39M
21
$3.2M
22
$3.08M
23
$2.96M
24
$2.96M
25
$2.96M
1
2 3